Tag: ALTUVIIIO

Ticagrelor reversal agent provides immediate and sustained effect

Efanesoctocog alfa in children with hemophilia A reduces bleeding

byJayden Berdugoand1 others

July 29, 2024

1. In this randomized controlled trial, a prophylactic weekly dose of efanesoctocog alfa (ALTUVIIIO) resulted in sustained factor VIII activity ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Two scores for risk stratification of adults presenting with syncope may be effective at identifying those with low risk
Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality
A novel therapy targeting γ-aminobutyric acid is safe and may be effective in major depressive disorder

No Result

View All Result